Should The U.S. Government Buy A Drug Company To Save Money?

Most of the millions in the U.S. who are infected with hepatitis C can't afford the cure. Some say the U.S. could save money and cure more people if it bought the drugmaker Gilead Sciences Inc.

 
More Headlines

Follow worldbiztoday on Twitter

US Stocks